CJC-1295 with DAC

Research reagent · CAS 863288-34-0 · Lyophilized vial

Product name	CJC-1295 with DAC
CAS number	863288-34-0
Sequence	Modified GRF 1-29 with Drug Affinity Complex
Form	Lyophilized vial
Storage	Sealed, dry, −20 °C, protect from light
Salt	Stated on lot COA

Presentations

Size	Availability
5 mg	Coming soon	Request quote

Overview

CJC-1295 with DAC (Drug Affinity Complex) is a modified GRF 1-29 reagent that incorporates a lysine-linked drug-affinity-complex moiety for albumin binding. The DAC modification extends the peptide's association with serum proteins in vitro. It is studied in growth-hormone-signaling models and protein-binding research. The catalog item is a research reagent, not a finished drug product. No dosing, injection, or administration guidance is provided.

Research context

Albumin-binding and pharmacokinetic modeling in vitro
Growth-hormone secretion models in pituitary cell culture
GRF receptor activation and signaling assays
Drug-affinity-complex conjugation studies
Peptide-protein interaction research

Documentation

A supplier Certificate of Analysis (COA) is a starting point. Released lots are verified by an independent U.S. laboratory:

Identity by LC-MS
HPLC purity
Peptide content
Salt composition
Endotoxin
Sterility when offered for sterile in-vitro work
Metals and water when on the panel

Certificates appear here when a lot is verified.

Research use only. Not a drug, pharmacy, or 503A/503B compounding facility. Not for human or veterinary use. This product is not intended to diagnose, treat, cure, or prevent any disease.

Request a quote

Tell us the size, quantity, and your institution. We respond within one business day.

5 mg — Request quote

Opens an email to purchasing@prosperresearchmaterialsllc.com